Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.

@article{Lichtenberg2001AreTB,
  title={Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.},
  author={Frank R. Lichtenberg},
  journal={Health affairs},
  year={2001},
  volume={20 5},
  pages={241-51}
}
This study analyzes data on prescribed medicines from the 1996 Medical Expenditure Panel Survey (MEPS) to examine the association between the use of newer medicines and morbidity, mortality, and health spending. We find that people consuming newer drugs were significantly less likely to die by the end of the survey and were significantly less likely to experience work-loss days than were people consuming older drugs. Our most notable finding, however, is that use of newer drugs tends to lower… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 61 extracted citations

Similar Papers

Loading similar papers…